Skip to content

Public FDA record

Z-1077-2013: ELEKTA MOSAIQ SW version below 2.41 Product Usage: The intended use of the SIEMENS branded ARTISTE and

Recall record Z-1077-2013 for Siemens Medical Solutions USA, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1077-2013
Company in FDA record
Siemens Medical Solutions USA, Inc
FDA classification date
Apr 10, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A potential safety risk with the MOSAIQ Oncology Information System that has been identified by the manufacturer IMPAC Medical Systems, Inc.

Source facts

Action
Siemens sent an Urgent Medical Device Correction letter with update instructions to all affected customers. The letter identified the affected product, problem and actions to be taken. For questions contact your responsible Siemens Service Engineer or Application Specialist.
Initiated
2012-12-20
Root cause
Software design
Terminated
2013-07-19
Distribution
Worldwide Distribution
Recall number
Z-1077-2013
Recall status
Terminated
CDRH record ID
115155
FDA classified
2013-04-10
Recall event number
63974

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗